Civil Society Public Forum on Therapeutic Goods Bill: Program, brief report and media coverage

A public forum was held at the Australian National University on 24 January, 2018  to air concerns about the impact on the regulation and advertising of complementary medicines under the Federal Government’s Therapeutic Goods Amendment (2017 Measures No. 1) Bill, The Bill was introduced to Parliament late last year and is currently before the Senate.

After discussion with Adjunct Prof John Skerritt, Deputy Secretary for Health Products Regulation, the Health Department Secretary, Glenys Beauchamp, instructed TGA staff not to attend this public forum.

Department of Health Secretary Glenys Beauchamp

Regardless, the Public Forum had excellent presentations, good questions from a varied audience and an informative panel debate.

One member of the panel, Tony Zappia MP (Shadow Assistant Minister for Medicare and the TGA) said that he valued attending the forum and that he would take the concerns expressed back to his parliamentary colleagues.

The program and a brief report on the proceedings is now available. A talk titled, ‘What claims should be permitted for therapeutic goods?‘ given by my students and me is also available.

Despite submissions being scheduled over the Christmas, New Year holiday period at least 55 submissions were received by the closing date of January 12, 2018. These are available on the Senate Inquiry web site.

In addition the issues raised have received extensive media coverage, for example:

The Senate Inquiry reporting date is  February 2, 2018.

Planning for monitoring the impact of whatever legislation eventuates continues (below):

ANU, Canberra, Monash University & Access 2 Public Hearing / TGA Planning Meeting


linkedinrsslinkedinrssby feather

About Dr Ken Harvey

Public Health Physician, Medical activitist
This entry was posted in Uncategorized and tagged , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.